Biomarin Pharmaceutical BMRN
NASDAQ BMRN
$55.76 +0.55 (+1.00%)
As of: Oct 22, 2026 · 9:59 AM EDT

Biomarin Pharmaceutical (BMRN) Long-Term Debt Issuances (2020 - 2026)

Updated

Biomarin Pharmaceutical (BMRN) reported Long-Term Debt Issuances of $2.8 billion for Q2 2026, up 229.4% from the prior quarter.

Analysis

Biomarin Pharmaceutical (BMRN) Long-Term Debt Issuances (2020 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Biomarin Pharmaceutical's Long-Term Debt Issuances came in at $3.65 billion; for FY2020, it was $585.75 million.

  • Long-Term Debt Issuances has a three-year compound annual growth rate of 6.7% (FY2017 to FY2020).
  • By year, Long-Term Debt Issuances came in at $481.71 million in FY2017.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Eli Lilly 1,157.52 Bn 1,126.11 Bn 19.71 Bn 8.94 Bn
2 Johnson & Johnson 631.39 Bn 549.92 Bn 17.26 Bn -
3 AbbVie 498.93 Bn 472.04 Bn 12.70 Bn -
4 Merck 376.05 Bn 330.42 Bn 12.21 Bn -
5 Novartis Ag 301.98 Bn 265.97 Bn 11.24 Bn 1.98 Bn
6 Astrazeneca 265.05 Bn 238.74 Bn 12.86 Bn -
7 Amgen 240.27 Bn 195.67 Bn 7.24 Bn -
8 Gilead Sciences 193.08 Bn 167.27 Bn 6.22 Bn -
9 Pfizer 171.85 Bn 118.50 Bn 10.94 Bn -
10 Biomarin Pharmaceutical 10.80 Bn 4.66 Bn 786.91 Mn 2.80 Bn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.80 Bn
Mar 31, 2026 850.00 Mn
Sep 30, 2020 -30,000.00
API Access

Biomarin Pharmaceutical Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=BMRN&period=max&api_key=YOUR_API_KEY